Matches in SemOpenAlex for { <https://semopenalex.org/work/W2997335410> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2997335410 endingPage "216" @default.
- W2997335410 startingPage "211" @default.
- W2997335410 abstract "Background The use of tranexamic acid (TXA) has recently gained popularity as a treatment modality for epistaxis in the emergency department. Previous studies have compared topical TXA to nasal packing. However, topical TXA has not yet been compared with topical oxymetazoline in the treatment of epistaxis. Objectives This study compares the efficacy of the intravenous formulation of TXA applied topically vs. the vasoconstrictor oxymetazoline applied topically in achieving hemostasis in patients presenting to the emergency department with anterior epistaxis. Methods In this prospective study, patients presenting to the emergency department with the chief complaint of epistaxis, and meeting inclusion criteria, were allocated into 2 treatment groups; topical oxymetazoline vs. topical application of the intravenous preparation of TXA. Patients were assessed for time to hemostasis in the emergency department as well as the occurrence of rebleeding within the next 48 h after discharge. Results Hemostasis was achieved in 14 (78%) of the 18 patients in the TXA group compared with 7 (35%) of the 20 patients in the oxymetazoline group. While there were occurrences of rebleeding in the emergency department before discharge and at 48 h in both groups, 11 patients in the TXA group had no recurrence of bleeding compared with 5 in the oxymetazoline group. Conclusion This study demonstrated that the topical application of the intravenous preparation of TXA is more effective than topical oxymetazoline for achievement of hemostasis in anterior epistaxis. This has clinical significance toward preventing an avoidable need for escalation of treatment that could include applying nasal packing or cautery as well as preventing avoidable return emergency department visits. These outcomes would increase cost, potentially increase patient discomfort, and prolong emergency department throughput time." @default.
- W2997335410 created "2020-01-10" @default.
- W2997335410 creator A5000165587 @default.
- W2997335410 creator A5061696523 @default.
- W2997335410 creator A5068995326 @default.
- W2997335410 creator A5087338160 @default.
- W2997335410 date "2020-02-01" @default.
- W2997335410 modified "2023-10-02" @default.
- W2997335410 title "Comparative Effectiveness of Topically Administered Tranexamic Acid Versus Topical Oxymetazoline Spray for Achieving Hemostasis in Epistaxis" @default.
- W2997335410 cites W2058865836 @default.
- W2997335410 cites W2151613568 @default.
- W2997335410 cites W2166087271 @default.
- W2997335410 cites W2317995893 @default.
- W2997335410 cites W2768018286 @default.
- W2997335410 cites W2790324064 @default.
- W2997335410 doi "https://doi.org/10.1016/j.jemermed.2019.11.038" @default.
- W2997335410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31899024" @default.
- W2997335410 hasPublicationYear "2020" @default.
- W2997335410 type Work @default.
- W2997335410 sameAs 2997335410 @default.
- W2997335410 citedByCount "13" @default.
- W2997335410 countsByYear W29973354102020 @default.
- W2997335410 countsByYear W29973354102021 @default.
- W2997335410 countsByYear W29973354102022 @default.
- W2997335410 countsByYear W29973354102023 @default.
- W2997335410 crossrefType "journal-article" @default.
- W2997335410 hasAuthorship W2997335410A5000165587 @default.
- W2997335410 hasAuthorship W2997335410A5061696523 @default.
- W2997335410 hasAuthorship W2997335410A5068995326 @default.
- W2997335410 hasAuthorship W2997335410A5087338160 @default.
- W2997335410 hasConcept C118552586 @default.
- W2997335410 hasConcept C126322002 @default.
- W2997335410 hasConcept C141071460 @default.
- W2997335410 hasConcept C170493617 @default.
- W2997335410 hasConcept C2778589496 @default.
- W2997335410 hasConcept C2779637338 @default.
- W2997335410 hasConcept C2780042274 @default.
- W2997335410 hasConcept C2780724011 @default.
- W2997335410 hasConcept C2991743468 @default.
- W2997335410 hasConcept C40465926 @default.
- W2997335410 hasConcept C42219234 @default.
- W2997335410 hasConcept C71924100 @default.
- W2997335410 hasConceptScore W2997335410C118552586 @default.
- W2997335410 hasConceptScore W2997335410C126322002 @default.
- W2997335410 hasConceptScore W2997335410C141071460 @default.
- W2997335410 hasConceptScore W2997335410C170493617 @default.
- W2997335410 hasConceptScore W2997335410C2778589496 @default.
- W2997335410 hasConceptScore W2997335410C2779637338 @default.
- W2997335410 hasConceptScore W2997335410C2780042274 @default.
- W2997335410 hasConceptScore W2997335410C2780724011 @default.
- W2997335410 hasConceptScore W2997335410C2991743468 @default.
- W2997335410 hasConceptScore W2997335410C40465926 @default.
- W2997335410 hasConceptScore W2997335410C42219234 @default.
- W2997335410 hasConceptScore W2997335410C71924100 @default.
- W2997335410 hasIssue "2" @default.
- W2997335410 hasLocation W29973354101 @default.
- W2997335410 hasOpenAccess W2997335410 @default.
- W2997335410 hasPrimaryLocation W29973354101 @default.
- W2997335410 hasRelatedWork W1979403001 @default.
- W2997335410 hasRelatedWork W2205554088 @default.
- W2997335410 hasRelatedWork W2315138922 @default.
- W2997335410 hasRelatedWork W2317612395 @default.
- W2997335410 hasRelatedWork W2328659429 @default.
- W2997335410 hasRelatedWork W2800022962 @default.
- W2997335410 hasRelatedWork W2997335410 @default.
- W2997335410 hasRelatedWork W3006341216 @default.
- W2997335410 hasRelatedWork W3009399736 @default.
- W2997335410 hasRelatedWork W3086340038 @default.
- W2997335410 hasVolume "58" @default.
- W2997335410 isParatext "false" @default.
- W2997335410 isRetracted "false" @default.
- W2997335410 magId "2997335410" @default.
- W2997335410 workType "article" @default.